C-reactive protein and uric acid roles in distinguishing ST-segment elevation myocardial infarction from
Batool Zamani1, Allahyar Golabchi2, Nasrin Ghadakkar1
1Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Insights
Serum C-reactive protein (CRP) and uric acid levels are significantly higher in ST-segment elevation myocardial infarction (STEMI) compared to non-ST-elevation acute coronary syndrome (NSTE ACS). These biomarkers may help differentiate STEMI from NSTE ACS.
Area of Science:
- Cardiology
- Biochemistry
- Inflammation Research
Background:
- Acute coronary syndrome (ACS) involves reduced blood flow to the heart, linked to systemic inflammation and biochemical factors.
- ST-segment elevation myocardial infarction (STEMI) and non-ST-elevation ACS (NSTE ACS) are common ACS subtypes requiring differentiation.
- Biomarkers like C-reactive protein (CRP) and uric acid are potential indicators of cardiovascular events.
Purpose of the Study:
- To investigate and compare serum levels of high-sensitivity C-reactive protein (hs-CRP) and uric acid in patients with STEMI versus NSTE ACS.
- To determine if these biochemical markers can distinguish between STEMI and NSTE ACS subtypes.
- To explore the potential of hs-CRP and uric acid as prognostic indicators in ACS.
Main Methods:
- A cohort of 140 ACS patients underwent coronary arteriography and were classified into STEMI and NSTE ACS groups.
- Serum levels of hs-CRP and uric acid were measured using standard clinical chemistry assays.
- Statistical analysis, including modeling, was employed to assess marker levels and their independence from confounding factors.
Main Results:
- Patients with STEMI exhibited significantly higher serum uric acid levels compared to those with NSTE ACS (P < .0001).
- Serum hs-CRP levels were also significantly elevated in STEMI patients relative to NSTE ACS patients (P < .0001).
- Elevated uric acid and hs-CRP in STEMI were found to be independent of age, gender, comorbidities, and family history (P < .001).
Conclusions:
- Serum hs-CRP and uric acid levels are significantly elevated in STEMI compared to NSTE ACS.
- These biomarkers may serve as valuable tools for differentiating between STEMI and NSTE ACS.
- hs-CRP and uric acid show potential as independent indicators for assessing disease severity and outcome in ACS patients.
Abstract:
Acute coronary syndrome (ACS) is defined as a range of conditions which the blood flow to the heart was reduced or stopped. This disorder is correlated to a systemic inflammatory response and some biochemical factors. Therefore, the aim of this study was investigations of serum C-reactive protein (CRP) and uric acid levels in ST-segment elevation myocardial infarction (STEMI) and non-ST-elevation ACS (NSTE ACS), as common subtypes of ACS. Patients with ACS (n = 140) were assessed with coronary arteriography and divided into STEMI and NSTE ACS groups. The serum levels of hs-CRP and uric acid were investigated using a routine clinical chemistry analyzer. Patients with STEMI showed a significant increase in uric acid level compared to those with NSTE ACS (P < .0001). Other data indicated that hs-CRP level in patients with STEMI was significantly higher than individuals with NSTE ACS (P < .0001). Modeling analysis revealed that the increased levels of acid uric and hs-CRP in patients with STEMI were independent of the effects of age, gender, background diseases, and familial history (P < .001). The current study provides further evidence to indicate that hs-CRP and uric acid may be considered as biofactors for comparing STEMI from NSTE ACS and determining disease outcome.
More Related Videos
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:30Acute Coronary Syndrome I: Introduction
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:27Myocarditis II: Clinical Features and Diagnostic Tests